2025. Use of SGLT2 inhibitors and agonists of GLP-1 receptors in cardiovascular diseases. Electronic Journal Collection Health. 25, 9 (Sep. 2025), e21512. DOI:https://doi.org/10.25248/reas.e21512.2025.